Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival - 30/05/13
This work was supported by grant nos. AI061093, AI071087, AI082713, and AI095848 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (to E.M.), K12HD0141401-10 from the NIH/National Institute of Child Health and Human Development (to N.R.), and MO 2160/2-1 from the German Research Foundation (to H.M.) and the Division of Intramural Research, NIAID, NIH (to S.M.H. and J.D.M.). |
|
All patient samples were collected in accordance with IRB-approved protocols. |
|
Disclosure of potential conflict of interest: N. Romberg has received grants from the National Institutes of Health-National Institute of Child Health and Human Development. H. Morbach has received grants from the German Research Foundation. I. Kang has received grants from the National Institutes of Health. E. Meffre has received grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases and has received payment for lectures from Genentech. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 131 - N° 6
P. 1691-1693 - juin 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?